title: sCTLA-4, CD4+CD25+Foxp3+ regulatory T cells in Behçet's disease patients.
authors.forename: N
authors.initials: N
authors.lastname: Demir
authors.forename: F
authors.initials: F
authors.lastname: Ilhan
authors.forename: T
authors.initials: T
authors.lastname: Demir
authors.forename: A
authors.initials: A
authors.lastname: Godekmerdan
mesh_terms: D001528:Behcet Syndrome / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D015415:Biomarkers / Q000378:metabolism; D018791:CD4 Lymphocyte Count; D060908:CTLA-4 Antigen / Q000097:blood*; D016022:Case-Control Studies; D051858:Forkhead Transcription Factors / Q000378:metabolism*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D053645:Interleukin-2 Receptor alpha Subunit / Q000378:metabolism*; D012074:Remission Induction; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000276:immunology*; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; C418974:FOXP3 protein, human; D051858:Forkhead Transcription Factors; C508017:IL2RA protein, human; D007166:Immunosuppressive Agents; D053645:Interleukin-2 Receptor alpha Subunit